News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
14,703 Results
Type
Article (667)
Company Profile (2)
Press Release (14034)
Section
Business (3447)
Career Advice (5)
Deals (595)
Drug Delivery (1)
Drug Development (2149)
FDA (691)
Job Trends (287)
News (6704)
Policy (500)
Tag
Academia (31)
Accelerated approval (2)
Adcomms (1)
Allergies (1)
Alliances (1038)
Alzheimer's disease (10)
Antibody-drug conjugate (ADC) (10)
Approvals (699)
Artificial intelligence (8)
Autoimmune disease (9)
Automation (3)
Bankruptcy (4)
Best Places to Work (256)
Biosimilars (4)
Bladder cancer (19)
Brain cancer (5)
Breast cancer (7)
Cancer (185)
Cardiovascular disease (10)
Career advice (5)
CAR-T (2)
Cell therapy (12)
Clinical research (1733)
Collaboration (51)
Compensation (33)
Complete response letters (1)
COVID-19 (51)
C-suite (13)
Cystic fibrosis (1)
Data (202)
Diabetes (20)
Diagnostics (152)
Drug discovery (3)
Drug pricing (2)
Duchenne muscular dystrophy (2)
Earnings (1567)
Events (2286)
Executive appointments (13)
FDA (794)
Frontotemporal dementia (1)
Funding (28)
Gene editing (1)
Generative AI (1)
Gene therapy (9)
GLP-1 (23)
Government (71)
Grass and pollen (1)
Guidances (20)
Healthcare (515)
Huntington's disease (1)
IgA nephropathy (19)
Immunology and inflammation (11)
Immuno-oncology (2)
Indications (2)
Infectious disease (59)
Intellectual property (6)
IPO (254)
Job creations (35)
Job search strategy (5)
Layoffs (7)
Legal (62)
Liver cancer (3)
Lung cancer (29)
Lymphoma (16)
Machine learning (4)
Manufacturing (16)
MASH (7)
Medical device (735)
Medtech (737)
Mergers & acquisitions (362)
Metabolic disorders (32)
Multiple sclerosis (1)
NASH (1)
Neurodegenerative disease (1)
Neuroscience (18)
NextGen: Class of 2026 (137)
Non-profit (29)
Obesity (5)
Opinion (3)
Ovarian cancer (2)
Pain (12)
Pancreatic cancer (7)
Parkinson's disease (1)
Patents (15)
Patient recruitment (18)
People (825)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase 1 (812)
Phase 2 (844)
Phase 3 (414)
Pipeline (196)
Postmarket research (28)
Preclinical (347)
Press Release (2)
Prostate cancer (11)
Psychedelics (1)
Radiopharmaceuticals (35)
Rare diseases (20)
Real estate (70)
Regulatory (483)
Reports (1)
Research institute (52)
Resumes & cover letters (1)
RSV (8)
Series A (5)
Series B (4)
Special edition (1)
Spinal muscular atrophy (1)
Startups (79)
Supply chain (4)
Vaccines (22)
Date
Today (2)
Last 7 days (18)
Last 30 days (57)
Last 365 days (764)
2026 (77)
2025 (777)
2024 (989)
2023 (1058)
2022 (1566)
2021 (1577)
2020 (1253)
2019 (882)
2018 (735)
2017 (705)
2016 (625)
2015 (747)
2014 (562)
2013 (464)
2012 (417)
2011 (496)
2010 (349)
Location
Africa (6)
Alabama (4)
Arizona (3)
Asia (1252)
Australia (179)
California (422)
Canada (41)
China (87)
Colorado (17)
Connecticut (10)
Delaware (7)
Europe (1715)
Florida (63)
Georgia (1)
Idaho (2)
Illinois (16)
Indiana (19)
Iowa (1)
Japan (8)
Kentucky (1)
Louisiana (2)
Maine (1)
Maryland (34)
Massachusetts (244)
Michigan (3)
Minnesota (13)
Mississippi (3)
Missouri (1)
Montana (11)
Nevada (2)
New Jersey (64)
New Mexico (1)
New York (36)
North Carolina (18)
Northern California (265)
Ohio (4)
Pennsylvania (57)
Rhode Island (1)
South America (8)
Southern California (103)
Tennessee (3)
Texas (31)
United States (1072)
Utah (4)
Virginia (2)
Washington State (3)
Wisconsin (7)
14,703 Results for "biomea fusion".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biomea Fusion Enters 2026 Focused on Executing Key Icovamenib and BMF-650 Milestones
January 12, 2026
·
8 min read
Press Releases
Biomea Fusion to Participate at Upcoming December 2025 Investor Conferences
November 24, 2025
·
1 min read
Press Releases
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025
·
1 min read
Press Releases
Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025
December 10, 2025
·
5 min read
Press Releases
Biomea Fusion to Participate at Jefferies London Healthcare Conference 2025
November 10, 2025
·
1 min read
Press Releases
Biomea Fusion to Present Poster Presentations at ObesityWeek®2025
October 31, 2025
·
2 min read
Press Releases
Biomea Fusion Announces Pricing of Public Offering of Securities
October 8, 2025
·
5 min read
Press Releases
Biomea Fusion Reports Third Quarter 2025 Financial Results and Corporate Highlights
November 4, 2025
·
11 min read
Press Releases
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - December 1, 2025
December 2, 2025
·
1 min read
Press Releases
Biomea Fusion Announces Oral Presentation of Icovamenib at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
December 2, 2025
·
2 min read
1 of 1,471
Next
